NCT03880708 China Inherited Ventricular Arrhythmias Registry
| NCT ID | NCT03880708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China National Center for Cardiovascular Diseases |
| Condition | Ventricular Arrythmia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-10-24 |
| Primary Completion | 2022-10-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-10-24 with a primary completion date of 2022-10-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.
Eligibility Criteria
Inclusion Criteria: * diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT). Exclusion Criteria: * patients were enrolled by other clinical trials.
Contact & Investigator
Yan YAO, MD, PhD
STUDY CHAIR
China National Center for Cardiovascular Diseases
Frequently Asked Questions
Who can join the NCT03880708 clinical trial?
This trial is open to participants of all sexes, aged 1 Hour or older, up to 90 Years, studying Ventricular Arrythmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03880708 currently recruiting?
Yes, NCT03880708 is actively recruiting participants. Contact the research team at ianyao@263.net.cn for enrollment information.
Where is the NCT03880708 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT03880708 clinical trial?
NCT03880708 is sponsored by China National Center for Cardiovascular Diseases. The principal investigator is Yan YAO, MD, PhD at China National Center for Cardiovascular Diseases. The trial plans to enroll 500 participants.